Indian stocks: Visit www.stage2stocks.com →

PRF Technologies Ltd.

Stage 4 · Declining · week 71

As of Oct 22, 2026, PRF Technologies is in Stage 4, the downtrend phase, now in week 71 (since May 30, 2025). It closed at $0.72, 89.1% below its 52-week high and below its 200-day average, which is falling.

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. More about the company

$0.72
-5.76% today
$2.5M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is PRFX early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 16w
S4 42w
S4 73w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 3w → S3 2w → S4 16w → S1 3w → S4 42w → S1 8w → S2 6w → S3 12w → S4 73w current
Total tracked: 165 weeks across 9 stage runs.

PRFX among Drug Manufacturers - Specialty & Generic76th of 84 by relative strength

All 84 →
Stocks in Drug Manufacturers - Specialty & Generic ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CPIXStage 2 · wk 2398+6.8%
2ETONStage 2 · wk 3097−10.1%
3ANIKStage 2 · wk 1596+3.5%
4IRWDStage 3 · wk 396−16.4%
5TEVAStage 2 · wk 995+3.1%
6AMRXStage 2 · wk 1995+5.9%
7KNSAStage 2 · wk 7395+6.2%
8AMLXStage 2 · wk 1593−6.6%
…76PRFXStage 4 · wk 718−28.0%
vs 52W High
-89.1%
$0.71 lo$6.60 hi
89.1% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 71
1w13w26w
Week 71, extended decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-62.7%
200 DMA: $1.93 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.12x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-28.0%
3M
-36.6%
6M
-70.1%
YTD
-79.4%
1Y
-88.8%
Scan Membership
Breakout Watch
Latest: 2025-01-22
3 appearances in last 60 days. First seen: 2023-05-05.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 71 · Vol 0.12x
2026-10-21S4
Wk 71 · Vol 0.06x
2026-10-20S4
Wk 70 · Vol 0.05x
2026-10-19S4
Wk 70 · Vol 0.26x
2026-10-16S4
Wk 70 · Vol 0.02x
2026-10-15S4
Wk 70 · Vol 0.11x
2026-10-14S4
Wk 70 · Vol 0.17x
2026-10-13S4
Wk 69 · Vol 0.14x
2026-10-12S4
Wk 69 · Vol 0.08x
2026-10-09S4
Wk 69 · Vol 0.10x
2026-10-08S4
Wk 69 · Vol 0.06x
2026-10-07S4
Wk 69 · Vol 0.04x
Moving averages & range
50 DMA
$0.93
200 DMA
$1.93
52W High
$6.60
52W Low
$0.71
5D Low
$0.71
Resistance levels (recent highs)
20d High
$0.98
60d High
$1.20
120d High
$3.00
250d High
$6.60
Next resistance
+35.7%
to 20d High
ROE
-45.3%
Profit margin 0.0%
Dividend Yield
0.00%
P/B 0.1

PRF Technologies: quick answers

What stage is PRF Technologies in?

As of Oct 22, 2026, PRF Technologies (PRFX) is in Stage 4, the downtrend phase. It entered Stage 4 on May 30, 2025 and is in week 71. What the four stages mean

Is PRF Technologies in an uptrend?

No. PRF Technologies is in a Stage 4 downtrend. It trades 62.7% below its 200-day average, which is falling.

How far is PRF Technologies from its 52-week high?

PRF Technologies closed at $0.72 on Oct 22, 2026, 89.1% below its 52-week high of $6.60. Its 52-week low is $0.71.

How has PRF Technologies performed over the past year?

As of Oct 22, 2026, PRF Technologies is down 88.8% over the past year and down 79.4% so far in 2026.

Which sector and industry is PRF Technologies in?

PRF Technologies is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - Specialty & Generic

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.